UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS — Los Angeles, California

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS is a clinical research site located in Los Angeles, California, United States 900951752.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS has participated in 26 clinical trials.

Therapeutic areas: HIV Infections, Influenza, Meningitis.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

• University of California Los Angeles School of Medicine
• Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
• VA Greater Los Angeles Health System
• Usc/Norris Comprehensive Cancer Center Hospital
• University of Southern California - PT Associates
• University of Southern California Keck School of Medicine/University of Southern California LAC & USC Medical Center
• UCLA Orthodpedic Hospital
• University of Southern California /ID# 164095
• Keck hospital of the University of Southern California
• Los Angeles Orthopedic Hospital, Orthopedic Hemophilia Treatment Center
• University of California Los Angeles - Division of Dermatology
• University California Los Angeles Medical Center (UCLA)

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS?

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS conducted?

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS has 26 clinical trials on record. Their work covers HIV Infections, Influenza, Meningitis.

Is UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS accredited by Crixeo Clinical Trials?

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.